Nuclear localization of factor inhibitor hypoxia-inducible factor in prostate cancer is associated with poor prognosis

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1513-1518

  Shaida, Nadeem ^a   Chan, Peter ^c   Turley, Helen ^b   Jones, Catherine M ^a   Kanga, Suresh ^a   Ritchie, Robert W ^a   Malone, Peter R ^a   Harris, Adrian L ^b   Fox, Stephen B ^c  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

HIF1AN protein; human; hypoxia inducible factor 1; local; neoplasm recurrence; prostate; prostatic neoplasms

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER RECURRENCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

CELL NUCLEUS; HUMANS; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; REPRESSOR PROTEINS; SURVIVAL RATE;

EID: 79952698125     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.12.001     Document Type: Article

References (30)

1. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38.
2. Fong GH and Takeda K: Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differentiation 2008; 15: 635.
3. Epstein AC, Gleadle JM, McNeill LA et al: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43.
4. Koivunen P, Hirsila M, Gunzler V et al: Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 2004; 279: 9899.
5. Boddy JL, Fox SB, Han C et al: The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer Clin Cancer Res 2005; 11: 7658.
6. Cookson MS, Aus G, Burnett AL et al: Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007; 177: 540.
7. Tan EY, Campo L, Han C et al: Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Breast Cancer Res 2007; 9: R89.
8. Pertschuk LP, Schaeffer H, Feldman JG et al: Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis. Lab Invest 1995; 73: 302.
9. Lando D, Peet DJ, Gorman JJ et al: FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002; 16: 1466.
10. Metzen E, Berchner-Pfannschmidt U, Stengel P et al: Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J Cell Sci 2003; 116: 1319.
11. Li J, Wang E, Dutta S et al: Protein kinase C-mediated modulation of FIH-1 expression by the homeodomain protein CDP/Cut/Cux. Mol Cell Biol 2007; 27: 7345.
12. Raval RR, Lau KW, Tran MG et al: Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005; 25: 5675.
13. Soilleux EJ, Turley H, Tian YM et al: Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues. Histopathology 2005; 47: 602.
14. Dayan F, Roux D, Brahimi-Horn MC et al: The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res 2006; 66: 3688.
15. Hu CJ, Sataur A, Wang L et al: The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 2007; 18: 4528.
16. Bellot G, Garcia-Medina R, Gounon P et al: Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29: 2570.
17. Vergis R, Corbishley CM, Norman AR et al: Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol 2008; 9: 342.
18. Santagata S, Demichelis F, Riva A et al: JAG-GED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 2004; 64: 6854.
19. Gustafsson MV, Zheng X, Pereira T et al: Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005; 9: 617.
20. Bin Hafeez B, Adhami VM, Asim M et al: Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 2009; 15: 452.
21. Zheng X, Linke S, Dias JM et al: Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci USA 2008; 105: 3368.
22. Wilkins SE, Hyvarinen J, Chicher J et al: Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1). Int J Biochem Cell Biol 2009; 41: 1563.
23. Sun HL, Liu YN, Huang YT et al: YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 2007; 26: 3941.
24. Lee DH and Lee YJ: Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. J Cell Biochem 2008; 105: 546.
25. Richardson PG, Xie W, Mitsiades C et al: Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol 2009; 27: 3518.
26. Kaluz S, Kaluzova M and Stanbridge EJ: Comment on the role of FIH in the inhibitory effect of bortezomib on hypoxia-inducible factor-1. Blood 2008; 111: 5258.
27. Shin DH, Chun YS, Lee DS et al: Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1. Blood 2008; 111: 3131.
28. Sakamoto T and Seiki M: Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1. J Biol Chem 2009; 284: 30350.
29. Ginouves A, Ilc K, Macias N et al: PHDs over-activation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis. Proc Natl Acad Sci USA 2008; 105: 4745.
30. Fukuba H, Takahashi T, Jin HG et al: Abundance of aspargynyl-hydroxylase FIH is regulated by Siah-1 under normoxic conditions. Neurosci Lett 2008; 433: 209.